FindTrial
Sign In

injectable naltrexone

DRUG6 trials

Sponsors

State University of New York - Upstate Medical University, University of Pennsylvania, Lifespan, University of Colorado, Denver

Conditions

Alcohol DependenceAlcohol Use DisorderBipolar DisordersHuman Immunodeficiency VirusOpiate DependenceOpioid-use DisorderSchizoaffective DisordersSchizophrenia

Early Phase 1

Medication Maintenance Therapy in Community Pharmacy Settings
CompletedNCT03766893
LifespanOpioid-use Disorder
Start: 2018-09-01End: 2018-12-31Updated: 2019-08-01

Phase 2

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
CompletedNCT01882361
University of PennsylvaniaHuman Immunodeficiency Virus, Opiate Dependence
Start: 2013-06-30End: 2020-07-31Updated: 2020-11-06
Medication Maintenance Therapy in Community Pharmacy Settings
NCT04139213
LifespanOpioid-use Disorder
Start: 2019-07-25End: 2022-10-01Target: 250Updated: 2022-08-24

Phase 4

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
CompletedNCT00453804
State University of New York - Upstate Medical UniversityAlcohol Dependence, Bipolar Disorders, Schizoaffective Disorders +1
Start: 2006-07-31End: 2007-06-30Target: 15Updated: 2008-03-18
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
TerminatedNCT00461890
State University of New York - Upstate Medical UniversityAlcohol Dependence, Veterans
Start: 2006-10-31End: 2007-12-31Target: 20Updated: 2011-10-24
In Hospital IM Naltrexone: A Pilot Study
WithdrawnNCT05087771
University of Colorado, DenverAlcohol Use Disorder
Start: 2022-03-31End: 2023-06-30Updated: 2023-04-07